Rett syndrome is a genetic neurodevelopmental disorder that affects mainly girls, but mutations in the causative MECP2 gene have also been identified in boys with classic Rett syndrome and Rett syndrome-like phenotypes. We have studied a group of 28 boys with a neurodevelopmental disorder, 13 of which with a Rett syndrome-like phenotype; the patients had diverse clinical presentations that included perturbations of the autistic spectrum, microcephaly, mental retardation, manual stereotypies, and epilepsy. We analyzed the complete coding region of the MECP2 gene, including the detection of large rearrangements, and we did not detect any pathogenic mutations in the MECP2 gene in these patients, in whom the genetic basis of disease remained unidentified. Thus, additional genes should be screened in this group of patients.
Hagberg B., Aicardi J., Dias K., Ramos O.A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol. 1983;14: 471-479.
2.
Amir RE, Van den Veyver IB, Wan M., Tran CQ, Francke U., Zoghbi HYRett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185-188.
3.
Trappe R., Laccone F., Cobilanschi J., et al. MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet. 2001;68:1093-1101.
4.
Hoffbuhr K., Devaney JM, LaFleur B., et al. MeCP2 mutations in children with and without the phenotype of Rett syndrome. Neurology. 2001;56:1486-1495.
5.
Leonard H., Silberstein J., Falk R., et al. Occurrence of Rett syndrome in boys. J Child Neurol. 2001;16:333-338.
6.
Ravn K., Nielsen JB, Uldall P., Hansen FJ, Schwartz M.No correlation between phenotype and genotype in boys with a truncating MECP2 mutation. J Med Genet.2003;40:e5.
7.
Topcu M., Akyerli C., Sayi A., et al. Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. Eur J Hum Genet. 2002 ;10:77-81.
8.
Zeev BB, Yaron Y., Schanen NC, et al. Rett syndrome: clinical manifestations in males with MECP2 mutations . J Child Neurol. 2002;17:20-24.
9.
Gomot M., Gendrot C., Verloes A., et al. MECP2 gene mutations in non-syndromic X-linked mental retardation: phenotype-genotype correlation. Am J Med Genet A. 2003;123:129-139.
10.
Dotti MT, Orrico A., De Stefano N., et al. A Rett syndrome MECP2 mutation that causes mental retardation in men. Neurology. 2002;58:226-230.
11.
Cohen D., Lazar G., Couvert P., et al. MECP2 mutation in a boy with language disorder and schizophrenia . Am J Psychiatry. 2002;159:148-149.
12.
Couvert P., Bienvenu T., Aquaviva C., et al. MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet. 2001;10:941-946.
13.
Klauck SM, Lindsay S., Beyer KS, Splitt M., Burn J., Poustka A.A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet. 2002;70:1034-1037.
14.
Winnepenninckx B., Errijgers V., Hayez-Delatte F., Reyniers E., Frank-Kooy R.Identification of a family with nonspecific mental retardation (MRX79) with the A140V mutation in the MECP2 gene: is there a need for routine screening?Hum Mutat. 2002 ;20:249-252.
15.
Kankirawatana P., Leonard H., Ellaway C., et al. Early progressive encephalopathy in boys and MECP2 mutations. Neurology. 2006;67:164-166.
16.
Villard L., Kpebe A., Cardoso C., Chelly PJ, Tardieu PM, Fontes M.Two affected boys in a Rett syndrome family: clinical and molecular findings . Neurology. 2000;55:1188-1193.
17.
Lynch SA, Whatley SD, Ramesh V., Sinha S., Ravine D.Sporadic case of fatal encephalopathy with neonatal onset associated with a T158M missense mutation in MECP2. Arch Dis Child Fetal Neonatal Ed. 2003;88:F250-F252.
18.
Kleefstra T. , Yntema HG, Nillesen WM, et al. MECP2 analysis in mentally retarded patients: implications for routine DNA diagnostics. Eur J Hum Genet. 2004;12:24-28.
19.
Moog U., Van Roozendaal K., Smeets E., et al. MECP2 mutations are an infrequent cause of mental retardation associated with neurological problems in male patients. Brain Dev. 2006;28: 305-310.
20.
Imessaoudene B., Bonnefont JP, Royer G., et al. MECP2 mutation in non-fatal, non-progressive encephalopathy in a male. J Med Genet. 2001 ;38:171-174.
21.
Clayton-Smith J., Watson P., Ramsden S., Black GCSomatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet. 2000;356:830-832.
22.
Watson P., Black G., Ramsden S., et al. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet . 2001;38:224-228.
23.
Wan M., Lee SS, Zhang X., et al. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet. 1999;65:1520-1529.
24.
Leuzzi V., Di Sabato ML, Zollino M., Montanaro ML, Seri S.Early-onset encephalopathy and cortical myoclonus in a boy with MECP2 gene mutation. Neurology. 2004;63:1968-1970.
25.
Yntema HG, Kleefstra T., Oudakker AR, et al. Low frequency of MECP2 mutations in mentally retarded males . Eur J Hum Genet. 2002;10:487-490.
26.
Meloni I., Bruttini M., Longo I., et al. A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet. 2000;67: 982-985.
27.
Kleefstra T. , Yntema HG, Oudakker AR, et al. De novo MECP2 frameshift mutation in a boy with moderate mental retardation, obesity and gynaecomastia. Clin Genet. 2002;61: 359-362.
28.
Venancio M. , Santos M., Pereira SA et al. An explanation for another familial case of Rett syndrome: maternal germline mosaicism. Eur J Hum Genet. 2002;15:902-904.
29.
Van Esch H. , Bauters M., Ignatius J., et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet. 2005;77:442-453.
30.
Orrico A., Lam C., Galli L., et al. MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett. 2000;481:285-288.
31.
Yntema HG, Oudakker AR, Kleefstra T., et al. In-frame deletion in MECP2 causes mild nonspecific mental retardation . Am J Med Genet. 2002;107:81-83.
32.
Carney RM, Wolpert CM, Ravan SA, et al. Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr Neurol. 2003;28:205-211.
33.
Hagberg B., Hanefeld F., Percy A., Skjeldal O.An update on clinically applicable diagnostic criteria in Rett syndrome . Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001. Eur J Paediatr Neurol. 2002;6: 293-297.
34.
Shi J., Shibayama A., Liu Q., et al. Detection of heterozygous deletions and duplications in the MECP2 gene in Rett syndrome by Robust Dosage PCR (RD-PCR). Hum Mutat. 2005;25:505.
35.
Shibayama A. , Cook , EH Jr, Feng J., et al. MECP2 structural and 3'-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism. Am J Med Genet B Neuropsychiatr Genet. 2004;128:50-53.
36.
Santos M., Yan J., Temudo T. et al. Analysis of highly conserved regions of the 3'UTR of MECP2 gene in patients with clinical diagnosis of Rett syndrome and other disorders associated with mental retardation. Dis Markers. 2008 ;24:319-324.
37.
Schanen C.Rethinking the fate of males with mutations in the gene that causes Rett syndrome . Brain Dev. 2001;23(suppl 1): S144-S146.
38.
Laumonnier F., Bonnet-Brilhault F., Gomot M., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet. 2004;74:552-557.
39.
Stromme P., Mangelsdorf ME, Shaw MA, et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat Genet. 2002;30:441-445.
40.
Kalscheuer VM, Tao J., Donnelly A., et al. Disruption of the serine/ threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation . Am J Hum Genet. 2003 ;72:1401-1411.
41.
Samaco RC, Nagarajan RP, Braunschweig D., LaSalle JMMultiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum Mol Genet . 2004;13:629-639.
42.
Chen WG, Chang Q., Lin Y., et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science. 2003;302:885-889.
43.
Martinowich K., Hattori D., Wu H., et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science . 2003;302:890-893.
44.
Horike S., Cai S., Miyano M., Cheng JF, Kohwi-Shigematsu T.Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome . Nat Genet. 2005;37:31-40.
